Professional Documents
Culture Documents
GUID - 4 en-US
GUID - 4 en-US
GUID - 4 en-US
Printed by: Elizabete Bete Official Date: Official as of 01-May-2020 Document Type: USP @2023 USPC
Do Not Distribute DOI Ref: gal6i DOI: https://doi.org/10.31003/USPNF_M18334_04_01
1
al
• Residue on Ignition á281ñ: NMT 0.1%, using a platinum
▲
• SPECTROSCOPIC IDENTIFICATION TESTS á197ñ, Infrared crucible
Spectroscopy: 197M▲ (CN 1-May-2020) ORGANIC IMPURITIES
ASSAY • Procedure
• PROCEDURE
ci Solution A, Mobile phase, System suitability solution, and
Solution A: 0.05 M monobasic sodium phosphate. Adjust Chromatographic system: Proceed as directed in the
with 85% phosphoric acid to a pH of 2.5. Assay.
Mobile phase: Acetonitrile, methanol, and Solution A Sample solution: 0.1 mg/mL of Clobetasol Propionate in
(19:4:17) Mobile phase
Internal standard solution: 0.2 mg/mL of beclomethasone Analysis
Sample: Sample solution
ffi
dipropionate in methanol
Standard solution: Dissolve a quantity of USP Clobetasol Calculate the percentage of each impurity in the portion of
Propionate RS in methanol and Internal standard solution to Clobetasol Propionate taken:
obtain a final solution of 0.04 mg/mL of USP Clobetasol
Propionate RS and 0.08 mg/mL of beclomethasone Result = (rU/rT) × 100
dipropionate.
rU = peak area for each impurity
O
https://online.uspnf.com/uspnf/document/1_GUID-5B365E21-6343-40BC-9ED4-430313F805FC_4_en-US 1/1